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INTRODUCTION
Intraoperative ultrasound (IOUS) is used in the 
operative treatment of primary and secondary hepatic 
tumours since the 70’s of the 20th century onwards 
(8). IOUS can detect additional lesions, especially 
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in metastatic neoplasms (2), it alters the surgical 
strategy in some patients (3) and helps preserving the 
hepatic parenchyma. When the operation is radical, 
this method defines the interrelations between the 
tumour and the vascular network (9). 
There are studies about the limited clinical 
value of IOUS (4,5) in detecting hepatic metastases of 
pancreatic cancer.
For these reasons we decided to assess the value 
of IOUS in detecting such liver metastases. 
MATERIAL AND METHODS
The study covered 16 patients, 9 males and 6 
females who had undergone operative intervention 
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for pancreatic carcinoma with hepatic metastases 
during the period 2007-2012. Patients’ average age 
was 65 years (range, 56-77 years). Fifteen patients 
presented with synchronous metastases and one 
patient with metachronous ones.
The liver was examined by US and CT 
preoperatively and during the surgical intervention 
by inspection, palpation and IOUS.
The examination was approved by the 
Ethic Committee of the Naval Hospital of Varna, 
Military Medical Academy. All the patients signed 
an informed consent before the examination and 
operation. All the procedures were in conformity 
with the requirements of the good clinical practice 
and ethical standards of the World Medical 
Association (Declaration from Helsinki for the rights 
of the examined patients).
RESULTS 
The maximum number of malignant hepatic 
lesions was 70 (Fig. 1). All of them were histologically 
confirmed. Twenty-eight lesions or 46,66% of all 
the lesions were found out by using preoperative US 
examination and 29 ones (48,33%) were established 
by means of preoperative CT (Fig. 1).
A total of 33 lesions sized <20 mm were detected 
by IOUS, 5 ones by CT and 3 ones by US. A total of 28 
lesions of a size between 20 and 30 mm were detected 
by IOUS, 25 by CT and 13 by US. Concerning 
the larger lesions, these three methods revealed 
comparable amounts of liver metastases (Fig. 2).
IOUS determined exactly the location of the 
metastases/The most commonly affected liver 
segments were IV, II and III according to Couinaud’s 
Diagnostic 
method
Pancreatic carcinoma/Liver segments Total MLL 
number
I II III IV V VI VII VIII
US - 4 3 6 4 6 3 2 28
CT - 3 2 7 5 6 4 3 29
IOUS - 13 12 14 8 9 7 7 70
Table 1. Number of metastases inn different liver segments detected by IOUS, US and CT
Diagnostic 
method









US 2 14 6  3 3 28
IOUS - 13 38 14  5 70
Table 2. Distribution of echogenicity of lesions revealed by US and IOUS
Fig. 1. Number of metastases revealed by IOUS, US and CT
Fig. 2. Number of lesions of different size detected by IOUS, 
US and CT
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classification (Table 1). The structural inhomogeneity 
in the region of the hepatic hilus could, probably, 
better explain the results of IOUS. Table 2 illustrated 
US appearance of the metastatic hepatic lesions 
according to the diagnostic method used.
A hypoechogenic metastasis measuring 6/8 mm 
that was not detected by intraoperative palpation was 
shown on Fig. 3. On Fig. 4 one could observe two 
isoechogenic metastases without halo and measuring 
9 mm and 10 mm, respectively, in a steatotic liver, hard 
to distinguish from the surrounding parenchyma. 
After hepatectomy, however, they were confirmed as 
metastases.
The information of IOUS changed the operative 
plan in 8/ out of 16 patients (50%). A biliary stent 
under IOUS control was placed in one patient with a 
severe hyperbilirubinemia of 466 µmol/L.
DISCUSSION
Approximately 90% of the patients die during 
the first year after diagnosing the pancreatic 
carcinoma and, therefore, it remains one of the 
most important problems in gastroenterology (6). 
The average age of our patients’ group is 65 years 
which is lower in comparison to the data of the 
surveillance, epidemiology and end results (SEER) 
trial that in 2004-2008, the average age of diagnosing 
this carcinoma is 72 years and the average age of 
death is 73 years (10). Besides liver metastases are 
predominantly synchronous (in 15 out of 16 patients 
or in 93,75% of the cases).
The number of lesions detected by IOUS 
considerably exceeds the number of those established 
by the other two diagnostic methods. IOUS detects 
70 metastases which are by two times more than 
these detected by CT and US. The average number of 
lesions found out in one patient by IOUS is over four, 
while the preoperative diagnostic methods detect 
less than two lesions only.
The analysis of the groups shows a great 
difference in detecting the malignant lesions by the 
preoperative imaging methods such as US and CT, on 
one hand, and IOUS, on the other hand, measuring 
is size between 10 and 20 mm. 
A total of 33 lesions sized <20 mm were detected 
by IOUS, 5 ones by CT and 3 ones by US. A total of 28 
lesions of a size between 20 and 30 mm were detected 
by IOUS, 25 by CT and 13 by US. A total of 33 out 
of 70 metastases (47,14%) of pancreatic carcinoma 
in our study are smaller than 20 mm in size. The 
average size of all the metastases is 21,88 mm in 
IOUS, 29,84 mm in CT and 33,08 mm in US. This 
is true for 95% of the cases where the three methods 
of imaging diagnostics are consecutively used. The 
minimum size of the metastases found by IOUS, CT 
and US is 10 mm, 19 mm and 18 mm, respectively. 
Most metastases are of mixed echogenicity (54,2%), 
a small part of them are isoechogenic (20%) and 
hypoechogenic (18,6%). It is an interesting fact 
that preoperative US examination establishes only 
6 metastases (21,4%) of mixed echogenicity. This 
Fig. 3. Hypoechogenic metastasis of pancreatic carcinoma
Fig. 4. Two isoechogenic metastases in the steatotic liver of 
pancreatic carcinoma
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discrepancy can be explained with the greater 
resolution of IOUS enabling the detection of more 
details of the examined structure.
The metastases show an almost regular 
distribution in both lobes of the liver. In IOUS, 39 
out of 70 of the lesions (55,7%) are in the left hepatic 
lobe and 31 out of 70 (44,3%) - in the right one. Most 
metastases are observed in IV segment (12/60; 20%) 
followed by those in II segment (11/60; 18,33%), and 
in III segment (10/60; 16,66%). The segments VII and 
VIII present with least metastases - 6/60 (10%) eachh. 
No metastases are establisehd in the first  segment. 
There is thrombosis of v. hepatica in one patient in 
this group.
According to the pathologists, there is no other 
organ giving metastases in the liver of such small 
size (7). In our study the metastases of pancreatic 
carcinoma have an average size of 21,88 mm and 
33/70 of the malignant hepatic lesions are smaller 
than 20 mm (47,14%).
According to the literature data, 35-40% of 
the cases of pancreatic carcinoma considered as 
resectable after CT, MRI, endoscopic retrograde 
cholangiopancreatography and angiography turned 
out to be inoperable due to hepatic metastases not 
proved by the preoperative examinations (1).  In our 
study multiple bilobar lesions (43,75%) are detected 
in 7 patients who are not suitable for resection. Four 
of them were revealed by IOUS and the other ones 
by intraoperative inspection and palpation. Three 
patients could not be resected because of advanced 
primary process. This suggests that the pancreatic 
carcinoma is detected either at an advanced stage 
of the primary malignancy, or at a stage of multiple 
hepatic metastases as a marker of poor prognosis.
CONCLUSION
IOUS detects by more than two times hepatic 
metastases in comparison to the preoperative US and 
CT. It helps changing the medical strategy in half 
of the patients and in the patients with mechanical 
jaundice and allows stent placement to alleviate 
patient’s status. We can draw the conclusion that 
IOUS should be applied as a routine practice in hepatic 
resections of pancreatic carcinoma metastases.
REFERENCES
1. Cerwenka, H., H. Bacher, G. Werkgartner, A. El-
Shabrawi, P. Kornprat, H. J. Mischinger, J. Raith. 
Accuracy of preoperative routine MRI for hepatic 
lesion detection.- Clin. Imaging, 30, 2006, No 3, 
186-189.
2. Conlon, R., M. Jacobs, D. Dasgupta, J. P. Lodge. 
The value of intraoperative ultrasound during 
hepatic resection  compared with improved 
preoperative magnetic resonance imaging.- Eur. J. 
Ultrasound, 16, 2003, No 3, 211-216.
3. D’Hondt, M., F. Vandenbroucke-Menu, S. Préville-
Ratelle, S. Turcotte, M. Chagnon, M. Plasse, et al. 
Is intra-operative ultrasound still useful for the 
detection of a hepatic tumour in the era of modern 
pre-operative imaging?- HPB (Oxford), 13, 2011, 
No 9, 665-669.
4. Finlayson, C., J. Hoffman, R. Yeung, H. Kessler, 
M. Guttmann, A. Shaer, M. Clair. Intraoperative 
ultrasound does not improve detection of liver 
metastases in resectable pancreatic cancer.- Am. J. 
Surg., 175, 1998, No 2, 99-101.
5. Flati, G., D. Flati, B. Porowska, E. Talarico, D. 
Tuscano, C. Talarico, M. la Pinta, M. Carboni. 
Is intraoperative ultrasonography useful in 
pancreatic cancer surgery?- G. Chir., 15, 1994, No 
6-7, 313-316.
6. Fry, L. C., K. Mönkemüller, P. Malfertheiner. 
Molecular markers of pancreatic cancer: 
development and clinical relevance.- Langenbecks 
Arch. Surg., 393, 2008, No 6, 883-890.
7. Graig, J. Liver.- In: Anderson’s Pathology. J. M. 
Kissane, ed. St. Louis etc., Mosby Co., 1990, 
1199-1320.
8. Makuuchi, M., K. Kamiya, M. Sugiura, et al. 
Ultrasonic examination by electronic scanning 
during operation.- In: Proceedings of the 32nd 
Meeting of the Japan Society of Ultrasonics in 
Medicine. 1977, 129-130.
9. Makuuchi, M.,  G. Torzilli, J. Machi. History of 
intraoperative ultrasound.- Ultrasound Med. Biol., 
24, 1998, No 9, 1229-1242.
10. Raimondi, S., P. Maisonneuve, A. B. Lowenfels 
Epidemiology of pancreatic cancer: an overview.- 
Nat. Rev. Gastroenterol. Hepatol., 6, 2009, No 12, 
699-708.
